Table 1.
Clinical details between TST positive and negative groups
| TST negative | TST positive | P value | |
|---|---|---|---|
| No. of cases | 179 | 21 | |
| Mean age (years) | 34.24 ± 10.9 | 38.3 ± 12.2 | 0.6 |
| Mean ± SD (range) | (14-60) | (19-60) | |
| % Males | 152 (84.9%) | 17 (80.9%) | 0.6 |
| Diabetes as cause of ESKD | 16 (9%) | 4 (19%) | 0.14 |
| Follow-up (months) | 33.4 ± 21.9 | 24.0 ± 13.4 | 0.05 |
| Mean ± SD (range) | (1-84) | (2-48) | |
| No of HD | 57.5 ± 49.9 | 51.9 ± 27.6 | 0.61 |
| Mean ± SD (range) | (1-414) | (0-100) | |
| No of BT | 4.5 ± 6.0 | 4.1 ± 5.1 | 0.76 |
| Mean ± SD (range) | (0-53) | (0-20) | |
| Pre-RT TB | 14 (7.8%) | 1 (4.8%) | 0.62 |
| HBV infection | 7 (3.9%) | Nil | 0.35 |
| HCV infection | 34 (18.9%) | 4 (19%) | 0.9 |
| Immunosuppression | |||
| Tacrolimus | 37 (20.7%) | 7 (33.3%) | 0.16 |
| MMF | 34 (19%) | 5 (23.8%) | 0.6 |
| Induction | 15 (8.4%) | 4 (19%) | 0.09 |
| No. of AR | 3 (15%) | Nil | 0.05 |
| Before post-RT TB no. of PTDM | 5 (25%) | Nil | 0.009 |
| Before post-RT TB no. of CMV | 1 (5%) | 1 (20%) | 0.008 |
| Before post-RT TB no. of cases developing TB | 20 (11.1%) | 5 (23.8%) | 0.08 |
| Mean time since RT (months) | 14 ± 6.9 | 14.8 ± 15.0 | 0.67 |
| Mean ± SD (range) | (3-21) | (1-47) |
TST = tuberculin skin test; ESKD = end stage kidney disease; HD = hemodialysis; BT = blood transfusion; RT = renal transplantation; TB = tuberculosis; AR = acute rejection; PTDM = post transplant diabetes mellitus; CMV = cytomegalovirus infection; HBV = hepatitis B virus; HCV = hepatitis C virus; <-before